Utilize este identificador para referenciar este registo: https://hdl.handle.net/10216/103360
Registo completo
Campo DCValorIdioma
dc.creatorCarlos Santos
dc.creatorTiago Neto
dc.creatorPedro Ferreirinha
dc.creatorHugo Sousa
dc.creatorJoana Ribeiro
dc.creatorMargarida M. S. M. Bastos
dc.creatorAna I. Faustino Rocha
dc.creatorPaula A. Oliveira
dc.creatorRui Medeiros
dc.creatorManuel Vilanova
dc.creatorGil da Costa, R. M.
dc.date.accessioned2023-07-20T23:25:28Z-
dc.date.available2023-07-20T23:25:28Z-
dc.date.issued2016-07-15
dc.identifier.issn0024-3205
dc.identifier.othersigarra:153301
dc.identifier.urihttps://hdl.handle.net/10216/103360-
dc.description.abstractAims: Human papillomavirus (HPV) is a known biologic carcinogen which is commonly transmitted through sexual intercourse. CD8(+) T cells are known effectors against tumour cells and an important prognostic marker in HPV-induced cancers. COX-2 inhibitors enhance CD8(+) T cell activity against some cancers. In this work, we sought to study the presence and activation of CD8(+) T lymphocytes in lesions from K14-HPV16 transgenic mice and the immunomodulatory effect of celecoxib (CXB) over these cells. Main methods: Skin samples of CXB-treated and untreated HPV16(-/-) and HPV16(+/-) mice were enzymatically digested and analysed by flow cytometry to assess CD8+ and CD8(+) CD107a(+) T cell infiltrates. Matched skin samples were classified histologically. Key findings: HPV16(+/-) mice presented higher CD8(+) T cell infiltration than HPV16(-/-) animals (P < 0.001). Older HPV16(+/-) animals showed epidermal dysplasia and increased percentages of CD8+ CD107a(+) T cells compared with younger animals with hyperplasia (P < 0.001), validating this model for testing the effects of celecoxib on CD8(+) T cells. CXB-treated HPV16(+/-) mice showed higher percentages of CD8(+) CD107a(+) T cells compared with untreated HPV16(+/-) animals (P < 0.01), but no differences were observed concerning the progression of epidermal lesions. Significance: These findings indicate that celecoxib enhances the degranulation of CD8(+) T cells on HPV16-induced lesions, suggesting the potential clinical use of COX-2 inhibitors. Additionally, this study demonstrates the usefulness of the K14-HPV16 mouse model for testing therapeutic immunomodulatory approaches.
dc.language.isoeng
dc.relationinfo:eu-repo/grantAgreement/FCT - Fundação para a Ciência e a Tecnologia/Projetos Estratégicos/UID/EQU/00511/2013 - POCI-01-0145-FEDER-006939/Laboratório de Engenharia de Processos, Ambiente, Biotecnologia e Energia/LEPABE
dc.rightsrestrictedAccess
dc.titleCelecoxib promotes degranulation of CD8(+) T cells in HPV-induced lesions of K14-HPV16 transgenic mice
dc.typeArtigo em Revista Científica Internacional
dc.contributor.uportoFaculdade de Engenharia
dc.contributor.uportoInstituto de Ciências Biomédicas Abel Salazar
dc.identifier.doi10.1016/j.lfs.2016.05.040
dc.identifier.authenticusP-00K-JKN
Aparece nas coleções:FEUP - Artigo em Revista Científica Internacional
ICBAS - Artigo em Revista Científica Internacional

Ficheiros deste registo:
Ficheiro Descrição TamanhoFormato 
153301.pdf
  Restricted Access
Artigo original publicado1.13 MBAdobe PDFVer/Abrir
153301.1.pdfPost-Print version1.51 MBAdobe PDFThumbnail
Ver/Abrir


Todos os registos no repositório estão protegidos por leis de copyright, com todos os direitos reservados.